These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15100157)

  • 1. NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation.
    Gurevich RM; Aplan PD; Humphries RK
    Blood; 2004 Aug; 104(4):1127-36. PubMed ID: 15100157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
    Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
    Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
    Hirose K; Abramovich C; Argiropoulos B; Humphries RK
    Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
    Pineault N; Abramovich C; Ohta H; Humphries RK
    Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the NUP98-CCDC28A fusion protein.
    Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
    Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.
    Gurevich RM; Rosten PM; Schwieger M; Stocking C; Humphries RK
    Exp Hematol; 2006 Sep; 34(9):1192-201. PubMed ID: 16939812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
    Nakamura T
    Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
    Yung E; Sekulovic S; Argiropoulos B; Lai CK; Leung M; Berg T; Vollett S; Chang VC; Wan A; Wong S; Humphries RK
    Leuk Res; 2011 Apr; 35(4):545-50. PubMed ID: 21130494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NUP98 gene fusions in hematologic malignancy.
    Slape C; Aplan PD
    Leuk Lymphoma; 2004 Jul; 45(7):1341-50. PubMed ID: 15359631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
    Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
    Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.
    Palmqvist L; Argiropoulos B; Pineault N; Abramovich C; Sly LM; Krystal G; Wan A; Humphries RK
    Blood; 2006 Aug; 108(3):1030-6. PubMed ID: 16861351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA.
    Pineault N; Abramovich C; Humphries RK
    Leukemia; 2005 Apr; 19(4):636-43. PubMed ID: 15744344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
    Gough SM; Slape CI; Aplan PD
    Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
    Nebral K; Schmidt HH; Haas OA; Strehl S
    Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.
    Mayotte N; Roy DC; Yao J; Kroon E; Sauvageau G
    Blood; 2002 Dec; 100(12):4177-84. PubMed ID: 12393433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP98 gene fusions in hematologic malignancies.
    Lam DH; Aplan PD
    Leukemia; 2001 Nov; 15(11):1689-95. PubMed ID: 11681408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.
    Saw J; Curtis DJ; Hussey DJ; Dobrovic A; Aplan PD; Slape CI
    Leuk Res; 2013 Dec; 37(12):1668-73. PubMed ID: 24090997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
    Takeda A; Goolsby C; Yaseen NR
    Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.